That means, among the risk factors for MASLD, only the effect of ISI on MASLD was independent of BMI
Research Use Only GLP-3 (Retatrutide) has not been evaluated by the FDA for safety or efficacy in humans
How to take retatrutide Retatrutide is expected to be a once-weekly injection that you can give yourself using a pen-style injector similar to existing GLP-1 medications
For those seeking more modest amounts of weight loss, any of the currently available medications are likely to work and the choice can be driven by a variety of factors: insurance coverage, availability, formulation (injection vs oral), and ease of access and use
11,12,19 Liraglutide appears to have the highest proportion of severe GI AEs, and dulaglutide shows the lowest